Today, FDA Commissioner, Scott Gottlieb, MD, spoke at our event, a dialogue on FDA’s first draft guidance on patient-focused drug development. Meeting participants engaged and interacted with people from various […]
Blog
The NHC Seeks Your Input
The National Health Council (NHC) is exploring how we communicate our work to members and to external audiences. For nearly 100 years, the NHC has been a strong and successful […]
Dialogue on Patient-Centered Value Assessment: Overcoming Barriers to Amplify the Patient Voice
On July 31, the National Health Council (NHC) hosted an invitational dialogue on Patient-Centered Value Assessment. We gathered a group of patient advocates and experts from value assessment organizations to […]
Trump Administration Releases Final Short-Term Plan Rule
Today, the Trump Administration announced the final rule that allows the purchase of short-term health plans with incomplete coverage compared to insurance plans under the Affordable Care Act (ACA). In […]
Welcome to the New NHC Blog: Putting Patients First
Welcome to the National Health Council Blog, Putting Patients First, where we’ll discuss trends, innovations, efforts, and challenges in patient-centered health care. Here we will highlight NHC programs, breaking news, […]
Tracking the Ways the Trump Administration has Decreased the Impact of Obamacare
Earlier this month, The New York Times began tracking ways the Trump Administration has been decreasing the impact of the Affordable Care Act (ACA). The authors, Haeyoun Park and Margot […]
FDA Commissioner Gottlieb to Keynote NHC’s 2018 Chief Medical/Scientific Officers Conference
We’re hosting our annual Chief Medical/Scientific Officers Conference on October 15-16 in Washington, DC. The theme this year is “Sharing Patient-Centered Outcomes Data: Building A Better Mousetrap Based on Learnings […]
Morning Consult OP-ED: FDA’s Acknowledgement of the Importance of Patient Engagement Welcomed
The National Health Council and the entire patient community embrace the Food and Drug Administration’s forward-thinking efforts to engage patients early and often to make drug development truly patient-focused. In […]